THE ANATOMY AND FUNCTION OF THE HUMAN LYMPHATIC SYSTEM IN AUTOIMMUNE DISEASES
Main Article Content
Keywords
Lymphatic system, autoimmune disease, inflammation, lymphangiogenesis, VEGF-C, immune regulation
Abstract
Background: The lymphatic system is important in the regulation of the immune system, in the clearance of antigens and in the maintenance of the balance in the tissue fluids. The evidence is growing more on the contribution of lymphatic dysfunction to the chronic inflammation in autoimmune diseases; however, the structural and functional changes of lymphatic have not been adequately investigated.
Objective: To evaluate anatomical and functional changes of the lymphatic system in autoimmune diseases and determine their association with disease activity and inflammatory markers.
Methodology: The analytical observational research was carried out at Muhammad College of Medicine, Peshawar between January 2025 and June 2025 and involved 72 patients who were confirmed to have autoimmune disorders. Standard disease activity indices were used to help patients fall into active and low/remission groups of the disease. Imaging methods were used to determine morphology of the lymphatics, and pumping frequency, tracer clearance time, and limb volume were used to determine lymphatic performance. Inflammatory and molecular markers including CRP, ESR, IL-6, and VEGF-C were analyzed. Statistical analysis was performed using SPSS, and p ≤ 0.05 was considered significant.
Results: Patients with active disease showed significantly enlarged lymph nodes, cortical thickening, dermal backflow, and dilated lymphatic vessels compared to remission patients. Functional assessment revealed reduced lymphatic pumping frequency and prolonged clearance time in active disease (p<0.001). Inflammatory markers including CRP, ESR, and IL-6 were significantly elevated, while VEGF-C levels suggested compensatory lymphangiogenesis. Lymphatic dysfunction was strongly associated with disease activity and clinical edema.
Conclusion: Autoimmune disease activity is associated with significant structural and functional impairment of the lymphatic system. Lymphatic evaluation may serve as a novel biomarker for disease severity and could represent a potential therapeutic target in chronic inflammatory disorders.
References
2. Petrova, T.V. and G.Y.J.S. Koh, Biological functions of lymphatic vessels. 2020. 369(6500): p. eaax4063.
3. Papadopoulos, Z., J. Herz, and J.J.T.J.o.I. Kipnis, Meningeal lymphatics: from anatomy to central nervous system immune surveillance. 2020. 204(2): p. 286-293.
4. Oliver, G., et al., The lymphatic vasculature in the 21st century: novel functional roles in homeostasis and disease. 2020. 182(2): p. 270-296.
5. Pan, Z., et al., Role of the CXCL13/CXCR5 axis in autoimmune diseases. 2022. 13: p. 850998.
6. Zhang, X., et al., The gut microbiota: emerging evidence in autoimmune diseases. 2020. 26(9): p. 862-873.
7. An, J., et al., The role of intestinal mucosal barrier in autoimmune disease: a potential target. 2022. 13: p. 871713.
8. Lee, D.S., O.L. Rojas, and J.L.J.N.r.D.d. Gommerman, B cell depletion therapies in autoimmune disease: advances and mechanistic insights. 2021. 20(3): p. 179-199.
9. Jiao, Y., et al., Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases. 2020. 11: p. 282.
10. Zinatizadeh, M.R., et al., The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases. 2021. 8(3): p. 287-297.
11. Bery, A.I., et al., Role of tertiary lymphoid organs in the regulation of immune responses in the periphery. 2022. 79(7): p. 359.
12. Brandum, E.P., et al., Dendritic cells and CCR7 expression: an important factor for autoimmune diseases, chronic inflammation, and cancer. 2021. 22(15): p. 8340.
13. Edner, N.M., et al., Targeting co-stimulatory molecules in autoimmune disease. 2020. 19(12): p. 860-883.
14. Cannas, D., et al., Relevance of essential trace elements in nutrition and drinking water for human health and autoimmune disease risk. 2020. 12(7): p. 2074.
15. Mouat, I.C., et al., Age-associated B cells in autoimmune diseases. 2022. 79(8): p. 402.
16. Mousa, W.K., F. Chehadeh, and S.J.F.i.i. Husband, Microbial dysbiosis in the gut drives systemic autoimmune diseases. 2022. 13: p. 906258.
17. Marković, I. and S.N.J.F.i.i. Savvides, Modulation of signaling mediated by TSLP and IL-7 in inflammation, autoimmune diseases, and cancer. 2020. 11: p. 1557.
18. Ning, Z., K. Liu, and H.J.F.i.I. Xiong, Roles of BTLA in immunity and immune disorders. 2021. 12: p. 654960.
19. Li, D.-Y. and X.-Z.J.F.i.i. Xiong, ICOS+ Tregs: a functional subset of Tregs in immune diseases. 2020. 11: p. 2104.
20. Yazar, S., et al., Single-cell eQTL mapping identifies cell type–specific genetic control of autoimmune disease. 2022. 376(6589): p. eabf3041.
21. Khalid, S., H. Asif, and M.J.P.J.o.H.S. Kabir, Immunity and Autoimmune system-a review: Immunity and Autoimmune system. 2021: p. 03-07.
22. BUILDER, V.J.M.s.P.f.M.P.-E.-B.M.s.P.f.M.P.-E.-B., Lymphatic System Review. 2021. 265.

